Amit Khot

Associate Professor

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Eric Youwei Wong

Deputy Director, Head of allogeneic stem cell transplantation

UTHealth

AUSTRALIA

View details

David Ritchie

Head of BMT

AUSTRALIA

View details

Constantine S. Tam

AUSTRALIA

View details

Karin Thursky

University of Melbourne

AUSTRALIA

View details

Ashley P. Ng

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amit Khot

Research Interests

Explore related searches

Contact this professor

Articles (12)

CD274 structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Lenalidomide maintenance in Myeloma – a goldilocks problem?

Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53-mutated disease

Del(1p32): prime time in (ultra) high-risk myeloma

Treatment approaches for patients with TP53-mutated mantle cell lymphoma.

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass index.

Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides

[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial.

The development of a home-based therapeutic platform for multiple myeloma.

Impact of an allied health prehabilitation service for haematologic patients receiving high-dose chemotherapy in a large cancer centre.

Collaborators (5)

Eric Youwei Wong

David Ritchie

Constantine S. Tam

Karin Thursky

Ashley P. Ng

Make your next move.